We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SILJ icon
26
Amplify Junior Silver Miners ETF
SILJ
$3.92B
$6.7M 0.7%
634,629
+207,005
+48% +$2.09M
PACX
27
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$6.34M 0.66%
625,000
+600,000
+2,400% +$6.03M
BNT
28
Brookfield Wealth Solutions
BNT
$12.1B
$5.81M 0.61%
278,750
+24,156
+9% +$642K
CBL
29
CBL Properties
CBL
$1.71B
$5.77M 0.6%
+250,000
New +$6.74M
HTZWW
30
Hertz Global Holdings Warrants
HTZWW
$92.9M
$5.22M 0.55%
700,355
+89,237
+15% +$787K
OSI
31
DELISTED
Osiris Acquisition Corp.
OSI
$4.97M 0.52%
+500,000
New +$4.97M
MRNA icon
32
PUT
Moderna
MRNA
$23.7B
$4.42M 0.46%
+16,300
New +$2.67M
NSTD
33
DELISTED
Northern Star Investment Corp. IV
NSTD
$4.27M 0.45%
+425,000
New +$4.23M
APYX icon
34
Apyx Medical
APYX
$152M
$4.16M 0.43%
1,775,793
-1,079,048
-38% -$3.29M
JNCE
35
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$4.05M 0.42%
3,647,430
SVFA
36
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$3.84M 0.4%
379,824
+335,146
+750% +$3.36M
NKGN
37
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$3.62M 0.38%
+363,598
New +$3.59M
BZAI
38
Blaize Holdings
BZAI
$154M
$3.34M 0.35%
+328,761
New +$3.32M
AMZN icon
39
Amazon
AMZN
$3.02T
$3.12M 0.33%
+37,127
New +$3.67M
IRRX
40
DELISTED
Integrated Rail and Resources Acquisition Corp.
IRRX
$3.09M 0.32%
+300,382
New +$3.05M
FSNB
41
DELISTED
Fusion Acquisition Corp. II
FSNB
$3.01M 0.31%
+299,870
New +$2.98M
EWT icon
42
iShares MSCI Taiwan ETF
EWT
$11B
$2.98M 0.31%
+74,193
New +$3.3M
C icon
43
Citigroup
C
$228B
$2.97M 0.31%
65,704
-139,240
-68% -$6.33M
TGT icon
44
Target
TGT
$68.9B
$2.96M 0.31%
19,867
-34,227
-63% -$5.37M
MRNA icon
45
Moderna
MRNA
$23.7B
$2.93M 0.31%
16,324
-16,978
-51% -$2.78M
META icon
46
Meta Platforms (Facebook)
META
$1.53T
$2.88M 0.3%
+23,910
New +$2.81M
CVII
47
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$2.84M 0.3%
+285,000
New +$2.83M
ADER
48
DELISTED
26 Capital Acquisition Corp
ADER
$2.79M 0.29%
+275,000
New +$2.75M
MRK icon
49
Merck
MRK
$321B
$2.77M 0.29%
+24,969
New +$2.55M
BREZ
50
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$2.61M 0.27%
250,000

Similar funds

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.